Strides Pharma Science

The Bengaluru-based company has received approval from the Drug Controller General of India to conduct human studies of…

The product is currently being exported to GCC countries to treat patients under their treatment program for COVID-19

Inspection conducted in January 2020 was for specific Extended Release applications  

The product is a generic version of Achromycin V Capsules, 250 mg and 500 mg, of Avet Pharmaceuticals Inc (previously Heritage…

Of the 18 products successfully developed by Pii with their Pharmaceutics know-how, 11 are currently approved by US FDA while the…

Consolidated EBITDA was at ₹1,851 million Strides Pharma Science has announced its Q3FY20 results. In Q3FY20, the consolidated…

Dr Ananthanarayanan will succeed Arun Kumar, Founder, and the incumbent CEO and MD of the company Strides Pharma Science has…

SPG will hold 70 per cent of the issued capital of Fairmed. Strides has infused CHF 2.2 Million into the entity in lieu of the…

The company announced a successful completion of inspection at the facility by US FDA with “Zero 483 observations”

During a panel discussion, experts discussed about new technologies, challenges in incorporating quality and compliance. It was…